In the detection of metastases, 68G-PSMA PET/CT imaging has high sensitivity, which leads to the transformation of patients from a non-metastatic disease state detected by traditional imaging to a metastatic disease state, thus changing the treatment strategy (19). Here, FOLH1 is linked to metastatic neoplasm.